Summary.-The carcinogenic effects of di-isopropanolnitrosamine (DIPN) were tested in hibernating and non-hibernating European hamsters. The results obtained were compared with those produced by the same substance in Syrian golden hamsters and Sprague-Dawley rats. In European hamsters, tumours were produced in the nasal cavity, trachea, lung, liver and pancreas. The main target organs were the anterior part of the nasal cavity and liver. Only cholangiomas and cholangiocarcinomas were found in the liver. Early changes in the intrahepatic bile ducts and duct epithelium of the pancreas were seen 4 weeks after treatment was started. Fourteen out of 144 treated hamsters developed pancreatic-duct tumours, 2 of which were malignant. The tumorigenic response in the target organs was lower in hibernating than in non-hibernating animals.
DI-ISOPROPANOLNITROSAMINE (DIPN)
primarily affected the pancreas, liver and kidneys of Syrian golden hamsters. It also induced neoplasms in the respiratory tract, mostly in the nasal cavities and lungs Pour et al., 1974; 1975a, b) . In contrast, DIPN treatment in rats resulted in the development of only one pancreatic tumour in 150 animals, most neoplasms occurring in the nasal cavities, thyroid gland, renal pelvis and liver (Mohr, Reznik and Pour, 1977; Reznik and Mohr, 1976) . This substance was therefore studied in European hamsters to obtain more information about its carcinogenic action.
MATERIALS AND METHODS
Experiments were conducted usino both hibernating and non-hibernating European hamsters. Six-month-old animals (strain: Mhh EPH) 8 weeks. After completion of this treatment, these animals were removed from cold laboratory conditions and subsequently maintained under standard laboratory conditions. Upon spontaneous death, the animals were examined at necropsy and all organs were fixed in 10% buffered formalin. Six-,um thick paraplast sections were stained with haematoxylin and eosin, periodic-acid-Schiff, alcian blue and Kreyberg's solution for histological examination.
RESULTS
The highest dose level (650 mg/kg) resulted in the early death (6-11 weeks) of both hibernating and non-hibernating animals, although the survival times demonstrated by the latter animals were still significantly shorter than that for the hibernating ones (Table I ). In contrast, the lowest dosage level (81.25 mg/kg) resulted in the hibernating animals dying earlier than the non-hibernators. The females lived on average 2-5 weeks longer than the males. With decreasing dosage the survival time increased (Table  I) . Table II gives the tumour distribution in all groups. The first neoplasms appeared in the non-hibernating animals of the highest dosage group after only 7 weeks of treatment, and were papillomas of the upper respiratory tract. These tumours originated from the epithelium of the anterior part of the nasal cavity (atrio-, naso-, and maxilloturbinals, nasal septum). The first malignant tumours were seen after 13 weeks of treatment. These were squamous-cell carcinomas and were again found mostly in the anterior part of the nasal septum, although a few were also deteoted in the ecto-and endoturbinals. All nonhibernating females of the lowest dosage group developed squamous-cell carcinomas of the nasal cavity. The nonhibernating animals of the dosage groups, 325, 162-5 and 81.25 mg/kg, had remarkably similar rates of nasal-cavity tumours. Both sexes of the two hibernating groups developed lower incidences of such tumours than the corresponding non-hibernators.
A number of papillary polyps were found in the trachea of both hibernating and non-hibernating animals. These showed no dose dependency for the nonhibernating animals, although significantly fewer were found in the lowest-dosage group of hibernators than in non-hibernators receiving the same dose level. Two female non-hibernators receiving 81V25 mg/kg demonstrated squamous-cell carcinomas of the trachea, while the males of this group exhibited small tumours as early as 10 weeks after the beginning of treatment.
Pulmonary neoplasms were seen in only 11/144 treated animals. These showed no dose dependency and were seen in both hibernators and non-hibernators. Two females developed adenocarcinom as (4) 12 (6) 8 (2) 8 (4) 4 (4) 3 (1) 9 (8) (one non-hibernator and one hibernator, both from the lowest dosage level). The benign tumours originated mostly from the lung parenchyma.
The liver of nearly all hamsters (with and without hibernation) treated with Early pancreatic changes were found in the high-dosage groups as soon as 5 weeks after beginning treatment; these were of fatty necrosis and were particularly prominent towards the rim of all parts of the pancreas (Fig. 2) . At the same time, acinar-cell atrophy and gobletcell metaplasia could be seen in the larger ducts (Fig. 3) . In animals that died after 1]0-15 weeks of treatment, ductal goblet-cell hyperplasia and periductal induration were seen (Fig. 4) . Intraductal polyps were diagnosed for 8/144 treated hamsters (Fig. 5) . Two adenocarcinomas of the ductal epithelium were found (female hibernator from 650 mg/kg and male non-hibernator from 81-25 mg/kg) after 12 and 20 weeks respectively (Fig. 6) . The tumour from the male infiltrated the mesenterium and showed compact nodules with poorly differentiated cells (Fig. 7) . Fourteen hamsters in all (10%) developed pancreatic tumours, while 10000 had proliferations and distensions of duct epithelia, partly with flattened cells, partly with cuboid epithelial cells. However, significantly fewer instances of fatty necrosis and acinar-cell atrophy were seen in the hibernating than in the nonhibernating animals. In addition to these findings, one adenocarcinoma of the descending colon and one of the uterus were found. Both tumours were seen in hibernating hamsters treated with 81 25 mg/kg.
I)1SCUSSION
Compared with the neoplastic effect of DIPN in the Syrian golden hamster (Pour et al., 1975a) and rat (Mohr et al., 1977) the present study showed several quite clear differences in both incidence and distribution of tumours. Noticeable, however, were the high rates of nasalcavity tumours seen in all 3 species, although the Syrian golden hamster developed considerably fewer squamous-cell carcinomas of this site than either of the other two species. Moreover, the first papilloma in Syrian golden hamsters was not described until after 16 weeks of treatment, while the European hamster demonstrated such tumours in the nasal cavities after only 7 weeks. No tracheal tumours were seen in rats after DIPN, whereas in European and Syriani goldenhamsters up to 5000 rates of tracheal papillary polyps were seen. The incidence of pulmonary neoplasms in the present study was markedly lower thaii that for all dose levels in the Syrian golden hamster (up to 855%) and in the rat (up to 72%).
A similarly high incidence of pulmonary tumours was also observed in rats after oral DIPN (Konishi et al., 1976a) . DIPN resulted in up to a 1000% rate of liver neoplasms in the Syrian golden hamster; histologically these were angiosarcomas, hepatocellular adenomas and cholangiocarcinomas. In rats (Mohr et al., 1977) and guinea-pigs (Rao and Reddy, 1977) most of the liver neoplasms induced were angiosarcomas, mixed-cell carcinomas and hepatocellular adenomas. In contrast to the present findings with the European hamster and earlier results with the Syrian golden hamster (Pour et al., 1 975a) , no cholangiomas or cholangiocarcinomas were found in the rat, and only a few in the guinea-pig. European hamsters with areas of proliferation of the bile-duct epithelium also exhibited early pancreatic changes: pancreatic duct distension and proliferation, as well as acinar-cell atrophy, fatty degeneration and necrosis. However, the latter three changes appeared less often in hibernating than in non-hibernating animals. Both the bile-duct and pancreatic-duct epithelia showed large numbers of goblet cells, indicating a pronounced toxicity of DJPN on liver and pancreas. As in the rat (Mohr et al., 1977) and the Syrian golden hamster (Pour et al., I 975a), single applications of DIPN exert no toxic effects in the European hamster. Therefore, differences in tumour incidence of these species cannot be related to differences in the metabolic rate of the compound. HoweveL, since multiple applications of DIPN resulted in a pronounced toxicity in the European hamster, some of its metabolites would seem to accum-ulate in this species. As with other hepatotropic carcinogens (Bannasch, 1975) , DIPN similarly resulted in the early development of cholangiofibrotic parts, with storage of mucoid substances. Investigations with DIPN in Syrian golden hamsters (Pour et al., 1 975a) , nitrosomethylurea in guineapigs (Reddy and Rao, 1975) , or 4-hydroxyaminoquinoline-1-oxide in rats (Hayashi and Hasegawa, 1971; Konishi et al., 1976b) also showed a necrotizing effect upon pancreatic acini similar to that seen in the present study. Ethionine in rats (Fitzgerald et al., 1968) and mice (Lombardi, 1976 ) also produced such results.
The present investigations with European hamsters have shown that this animal is more sensitive to the acute toxic effects of DIPN than the Syrian golden hamster or rat. The early changes in the liver and pancreas led to the early death of the animals. This indicates that further investigations with DIPN are needed to find a dosage or treatment scheme that exerts a less toxic effect on such organs, and thus could result in higher tumour incidences. The fact that only one liver tumour was found in the hibernating animals of the highest-dose group would suggest that hibernation alters the neoplastic influence of this substance. Some such influence of hibernation would also be suggested by the decrease in toxic pancreatic alterations (fatty necrosis, acinar-cell atrophy) seen for hibernating animals. A reduction in the metabolism of DIPN during hibernation could account for this phenomenon.
